Correlates of benzodiazepine use in individuals with insomnia

Sleep Medicine

Volumn 5, Issue 5, 2004, Pages 457-462

  Morin, Charles M ^a,b   Bélanger, Lynda ^a,b   Bernier, Fraņois ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Benzodiazepines; Hypnotics; Insomnia; Long term use; Psychosocial factors

Indexed keywords

BENZODIAZEPINE;

ADULT; AGE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; DRUG USE; FEMALE; HEALTH CARE FACILITY; HUMAN; INSOMNIA; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; SLEEP DISORDER; SLEEP WAKING CYCLE; SYMPTOMATOLOGY;

ADULT; AGE FACTORS; ANTI-ANXIETY AGENTS; ANXIETY; BENZODIAZEPINES; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSION; DRUG UTILIZATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LONG-TERM CARE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; WAKEFULNESS;

EID: 4444383948     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2004.04.001     Document Type: Article

References (41)

1. Ohayon M.M. Epidemiology of insomnia: What we know and what we still need to learn Sleep Med Rev 6 2002 97-111
2. Dunbar G.C. Perera M.H. Jenner F.A. Pattern of benzodiazepine use in Great Britain as measured by a general population survey Br J Psychiatry 155 1989 836-841
3. Lacks P. Powlishta K. Improvement following behavioral treatment for insomnia: Clinical significance, long-term maintenance, and predictors of outcome Behav Ther 20 1989 117-134
4. Mellinger G.D. Balter M.B. Uhlenhuth E.H. Insomnia and its treatment: prevalence and correlates Arch Gen Psychiatry 42 1985 225-232
5. Quera-Salva M.-A. Orluc A. Goldberg F. Guilleminault C. Insomnia and the use of hypnotics: study of a French population Sleep 14 1991 386-391
6. Hohagen F. Käppler C. Schramm E. Rink K. Weyerer S. Riemann D. Berger M. Prevalence of insomnia in elderly general practice attenders and the current treatment modalities Acta Psychiatr Scand 90 1994 102-108
7. Mant A. Mattick R.P. de Burgh S. Donnelly N. Hall W. Benzodiazepine prescribing in general practice: dispelling some myths Fam Pract 12 1995 37-43
8. Ohayon M.M. Caulet M. Psychotropic medication and insomnia complaints in two epidemiological studies Can J Psychiatry 41 1996 457-464
9. Walsh J.K. Schweitzer P.K. Ten-year trends in the pharmacological treatment of insomnia Sleep 22 1999 371-375
10. Kripke D.F. Klauber M.R. Wingard D.L. et al. Mortality hazards associated with prescription hypnotics Biol Psychiatry 43 1998 687-693
11. Simon G.E. VonKorff M. Barlow W. Pabiniak C. Wagner E. Predictors of chronic benzodiazepine use in a health maintenance organization sample J Clin Epidemiol 49 1996 1067-1073
12. National Institutes of Health (NIH) Drugs and insomnia: The use of medications to promote sleep J Am Med Assoc 18 1984 2410-2414
13. Moskowitz H. Linnoila M. Roehrs T. Psychomotor performance in chronic insomniacs during 14-day use of Flurazepam and Midazolam J Clin Psychopharmacol 10 1990 44S-55S
14. Soldatos C.R. Dikeos D.G. Whitehead A. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta analysis of sleep laboratory studies Int Clin Psychopharmacol 14 1999 287-303
15. Lader M. Biological processes in benzodiazepine dependence Addiction 89 1994 1413-1418
16. National Institutes of Health Consensus development conference statement: the treatment of sleep disorders of older people Sleep 14 1991 169-177
17. Egan M. Morides Y. Wolfson C. Monette J. Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors J Am Ger Soc 48 2000 811-816
18. Laurier C. Dumas J. Grégoire J.-P. Factors related to benzodiazepine use in Quebec: a secondary analysis of survey data J Pharmacoepidemiol 2 1992 73-86
19. Tamblyn R.M. McLoead P.J. Abrahamovitz M. Monette J. Gayton D.C. Berkson L. et al. Questionable prescribing for elderly patients in Quebec Can Med Assoc J 150 1994 1801-1809
20. Swartz M. Landerman R. George L.K. Melville M. Blazer D. Smith K. Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a Southern community Am J Public Health 81 1991 592-596
21. Morin C.M. Insomnia: psychological assessment and management 1993 Guilford New York, NY
22. Blais F.C. Gendron L. Mimeault V. Evaluation de l'insomnie: Validation de trois questionnaires L'Encéphale 23 1997 447-453
23. Bastien C.H. Vallières A. Morin C.M. Validation of the Insomnia Severity Index as a clinical outcome measure for insomnia research Sleep Med 2 2001 297-307
24. Coates T.J. Killen J.D. George J. Marchini E. Silverman S. Thoresen C. Estimating sleep parameters: a multitrait-multimethod analysis J Consult Clin Psychol 50 1982 345-352
25. Lacks P. Morin C.M. Recent advances in the assessment and treatment of insomnia J Consult Clin Psychol 60 1992 586-594
26. Lichstein K.L. Riedel B.W. Behavioral assessment and treatment of insomnia: A review with an emphasis on clinical application Behav Ther 25 1994 659-688
27. Beck A.T. Ward C.H. Mendelson M. Mock J. Erbaugh J. An inventory for measuring depression Arch Gen Psychiatry 4 1961 561-571
28. Spielberger C.D. Gorshuch R.L. Lushene R.E. Manual for the State-Trait Anxiety Inventory 1970 Consulting Psychologist Palo Alto, CA
29. American Psychiatric Association Diagnostic and statistical manual of mental disorders 3rd ed. revised 1987 Author Washington, DC
30. Leipzig R.M. Cumming R.G. Tinetti M.E. Drugs and falls in older people: a systematic review and meta-analysis: psychotropic drugs J Am Ger Soc 47 1999 30-39
31. Ray W.A. Griffin M.R. Schaffner W. Bauth D.K. Melton L.J. Psychotropic drug use and the risk of hip fracture N Engl J Med 316 1987 363-369
32. Ray W.A. Thapa P.B. Gideon P. Benzodiazepines and the risk of falls in nursing home residents J Am Ger Soc 48 2000 682-685
33. Ray W.A. Fought R.L. Decker M.D. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers Am J Epidemiol 136 1992 873-883
34. Hemmelgarn B. Suissa S. Huang A. Boivin J.F. Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly J Am Med Assoc 278 1997 27-31
35. Bixler E.O. Kales A. Soldatos C.R. Kales J.D. Healy B. Prevalence of sleep disorders in the Los Angeles metropolitan area Am J Psychiatry 136 1979 125-1262
36. Neiman J. Persson H. Bergman H. Early benzodiazepine withdrawal in benzodiazepine-dependent subjects: a pilot study Nord J Psychiatry 48 1994 19-25
37. Rickels K. Schweizer E. Case W.G. Greenblatt D.J. Long term therapeutic use of benzodiazepine: effects of abrupt discontinuation Arch Gen Psychiatry 47 1990 899-907
38. Brady K.T. Johnston A.L. Cunningham M. Malcom R. Profiles of hospitalized benzodiazepine abusers J Psychoactive Drugs 23 1991 71-72
39. Busto U.E. Romach M.K. Sellers E.M. Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence J Clin Psychopharmacol 16 1996 51-57
40. Vanable P.A. Aikens J.E. Tadimeti L. Caruana-Montaldo B. Mendelson W.B. Sleep latency and duration estimates among sleep disorder patients: variability as a function of sleep disorder diagnosis, sleep history and psychological characteristics Sleep 23 2000 71-79
41. Edinger J.D. Fins A.I. The sleep distribution an clinical significance of sleep time misperception among insomniacs Sleep 18 1995 232-239